Evidence map›Paper›PMID 23828390›Full record

ArticleNature communications2013

Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studies.

Steen U Hansen, Gavin J Miller, Claire Cole, Graham Rushton, Egle Avizienyte, Gordon C Jayson, John M Gardiner

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Automated Solid Phase Assisted Synthesis of a Heparan Sulfate Disaccharide Library.Organic chemistry frontiers : an international journal of organic chemistry · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Glycans in drug discovery.MedChemComm · 2019
    Review
  12. Controlled Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides.Angewandte Chemie (International ed. in English) · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The design and synthesis of new synthetic low-molecular-weight heparins.Journal of thrombosis and haemostasis : JTH · 2016
    Review
  18. Article
  19. Divergent Synthesis of Heparan Sulfate Oligosaccharides.The Journal of organic chemistry · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Steen U HansenFaculty of EPS, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester M1 7DN, UK.
Gavin J Miller
Claire Cole
Graham Rushton
Egle Avizienyte
Gordon C Jayson
John M Gardiner
University of Manchester · GB

Funding

Cancer Research UK C2075/A9106Medical Research Council G0601746Medical Research Council G0902173Medical Research Council G902173
6 · The paper itself

Abstract

Heparin-like oligosaccharides mediate numerous important biological interactions, of which many are implicated in various diseases. Synthetic improvements are central to the development of such oligosaccharides as therapeutics and, in addition, there are no methods to elucidate the pharmacokinetics of structurally defined heparin-like oligosaccharides. Here we report an efficient two-cycle [4+4+4] tetrasaccharide-iteration-based approach for rapid chemical synthesis of a structurally defined heparin-related dodecasaccharide, combined with the incorporation of a latent aldehyde tag, unmasked in the final step of chemical synthesis, providing a generic end group for labelling/conjugation. We exploit this latent aldehyde tag for (3)H radiolabelling to provide the first example of this kind of agent for monitoring in vivo tissue distribution and in vivo stability of a biologically active, structurally defined heparin related dodecasaccharide. Such studies are critical for the development of related saccharide therapeutics, and the data here establish that a biologically active, synthetic, heparin-like dodecasaccharide provides good organ distribution, and serum lifetimes relevant to developing future oligosaccharide therapeutics.

Indexed as

Isotope LabelingAnimalsChromatography, GelChromatography, High Pressure LiquidFemaleHeparinKidneyMagnetic Resonance SpectroscopyMiceMice, SCIDOligosaccharidesReproducibility of ResultsTissue DistributionTritiumHeparinOligosaccharidesTritium

Identifiers

PMID23828390
PMCPMC3715853
OpenAlexW2020871302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.